Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Overexpression of Pokemon in non-small cell lung cancer and foreshowing tumor biological behavior as well as clinical results

12 Jun 2008

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer-related Molecular Pathways
Share to Glycosylation and Glycoproteins Research
Share to HER2/EGFR in Cancer Research

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 18550205
DOI: 10.1016/j.lungcan.2008.02.014

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Overexpression of Pokemon in non-small cell lung cancer and foreshowing tumor biological behavior as well as clinical resultsPMID 18550205Read ↗

The Transcription Factor Pokemon: A New Key Player in Cancer PathogenesisSemantic proximity Read ↗

Pro-oncogene Pokemon promotes breast cancer progression by upregulating survivin expressionSemantic proximity Read ↗

Analyses of expressions and prognostic values of Polo-like kinases in non-small cell lung cancer.Semantic proximity Read ↗

PLEK2 activates the PI3K/AKT signaling pathway to drive lung adenocarcinoma progression by upregulating SPC25Semantic proximity Read ↗

PLEK2 promotes lung adenocarcinoma progression via activating the PI3K/AKT signaling pathway through SPC25 Running title: PLEK2 promotes LUAD via SPC25/PI3K/AKT axisSemantic proximity Read ↗

Overexpression and Selective Anticancer Efficacy of ENO3 in STK11 Mutant Lung Cancers.Semantic proximity Read ↗

POU2F3 in SCLC: Clinicopathologic and Genomic Analysis With a Focus on Its Diagnostic Utility in Neuroendocrine-Low SCLCSemantic proximity Read ↗

POU2AF2/C11orf53 functions as a co-activator of POU2F3 by maintaining chromatin accessibility and enhancer activitySemantic proximity Read ↗

RYBP predicts survival of patients with non-small cell lung cancer and regulates tumor cell growth and the response to chemotherapySemantic proximity Read ↗

Bioinformatics Analysis Combined With Experiments Predicts CENPK as a Potential Prognostic Factor for Lung AdenocarcinomaSemantic proximity Read ↗

The role of CENPO expression in the progression of non-small cell lung cancerSemantic proximity Read ↗

The effects of PEDF on cancer biology: mechanisms of action and therapeutic potentialSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.